David G. Standaert

Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

Robert G. Holloway, Ira Shoulson, Karl Kieburtz et al. · JAMA · 2000 · 802 citations

Initial Treatment, Parkinson Disease, Medicine +5

Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease

Anthone W. Dunah, Hyunkyung Jeong, April M. Griffin et al. · Science · 2002 · 702 citations

Knockout Mouse, Transcriptional Regulation, Neurodegenerative Diseases +14

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

Advanced Parkinson, Continuous Intrajejunal Infusion, Neurology +3

Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors

Shyamal Patel, Konrad Lorincz, R. Hughes et al. · IEEE Transactions on Information Technology in Biomedicine · 2009 · 607 citations · Full text

Wearable System, Accelerometer, Wearable Technology +19

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Jiang‐Fan Chen, Zhihong Huang, Jianya Ma et al. · PubMed · 1999 · 531 citations · Full text

Transient Focal Ischemia, Social Sciences, Cerebral Vascular Regulation +19